Complete response of colorectal liver metastases after chemotherapy: does it mean cure?

[1]  S. Curley,et al.  Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  N. Petrelli,et al.  Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit? , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Janice Ward,et al.  Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging. , 2005, Radiology.

[4]  A. Zwinderman,et al.  Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis. , 2005, Radiology.

[5]  M. Posner,et al.  Determinants of unresectability and outcome of patients with occult colorectal hepatic metastases , 2005, Journal of surgical oncology.

[6]  C. Bokemeyer,et al.  Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  M. Valerio,et al.  Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  N. Petrelli,et al.  Hepatic resection: the last surgical frontier for colorectal cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  W. Hawkins,et al.  Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. , 2005, Journal of the American College of Surgeons.

[10]  N. Kemeny,et al.  Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  T. Baère,et al.  Incidence of Unsuspected and Treatable Metastatic Disease Associated With Operable Colorectal Liver Metastases Discovered Only at Laparotomy (and Not Treated When Performing Percutaneous Radiofrequency Ablation) , 2005, Annals of Surgical Oncology.

[12]  A. Jemal,et al.  Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.

[13]  A. Shirkhoda,et al.  Morphologic changes of the liver following chemotherapy for metastatic breast carcinoma: CT findings , 2005, Abdominal Imaging.

[14]  F. Lévi,et al.  Tumor Progression While on Chemotherapy: A Contraindication to Liver Resection for Multiple Colorectal Metastases? , 2004, Annals of surgery.

[15]  Bernard Paule,et al.  Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by Chemotherapy: A Model to Predict Long-term Survival , 2004, Annals of surgery.

[16]  B. Davidson,et al.  Prospective study of contrast‐enhanced computed tomography, computed tomography during arterioportography, and magnetic resonance imaging for staging colorectal liver metastases for liver resection , 2004, The British journal of surgery.

[17]  D. Sahani,et al.  Intraoperative US in patients undergoing surgery for liver neoplasms: comparison with MR imaging. , 2004, Radiology.

[18]  B. Siegel,et al.  Five-Year Survival After Resection of Hepatic Metastases From Colorectal Cancer in Patients Screened by Positron Emission Tomography With F-18 Fluorodeoxyglucose (FDG-PET) , 2004, Annals of surgery.

[19]  J. Berlin,et al.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. , 2004, The New England journal of medicine.

[20]  F. Giuliante,et al.  Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  M. Ducreux,et al.  Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy , 2004, Journal of surgical oncology.

[22]  O. Bathe.  Preoperative chemotherapy for liver metastases: A contemporary approach giving rise to new questions , 2004, Journal of surgical oncology.

[23]  C. Bartolozzi,et al.  Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT , 2004, European Radiology.

[24]  Richard Stang,et al.  Resection of colorectal liver metastases , 1997, Journal of Gastrointestinal Surgery.

[25]  K. Sugimura,et al.  Tumor response to chemotherapy: The validity and reproducibility of RECIST guidelines in NSCLC patients 1 , 2003, Cancer Science.

[26]  W. Jarnagin,et al.  Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases , 2003, Journal of Gastrointestinal Surgery.

[27]  M. Rivoire,et al.  Combination of neoadjuvant chemotherapy with cryotherapy and surgical resection for the treatment of unresectable liver metastases from colorectal carcinoma , 2002, Cancer.

[28]  C. Lombard-Bohas,et al.  Assessment of tumour response to chemotherapy for metastatic colorectal cancer: accuracy of the RECIST criteria. , 2002, The British journal of radiology.

[29]  J. Figueras,et al.  Hepatic metastases from colorectal cancer: preoperative detection and assessment of resectability with helical CT. , 2001, Radiology.

[30]  C. Wilson,et al.  Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  R. James,et al.  Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial , 2000, The Lancet.

[32]  M. van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.

[33]  L. Ellis,et al.  Surgery After Downstaging of Unresectable Hepatic Tumors With Intra-Arterial Chemotherapy , 2000, Annals of Surgical Oncology.

[34]  A. Altendorf-Hofmann,et al.  Factors influencing the natural history of colorectal liver metastases , 1994, The Lancet.

[35]  J. Scheele.  Hepatectomy for liver metastases , 1993, The British journal of surgery.

[36]  J. Fortner,et al.  Multivariate Analysis of a Personal Series of 247 Consecutive Patients with Liver Metastases from Colorectal Cancer: I. Treatment by Hepatic Resection , 1984, Annals of surgery.